No photo of Michael G Ison

View Scopus Profile

Michael G Ison

  • 5723 Citations
19972020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

My primary clinical and research area focuses on infections in transplant recipients. My research is further focused on viral infections including norovirus, CMV and respiratory viral infections (influenza, adenovirus) in transplant recipients.

Care of the transplant recipient with infections.

Certifications and Licenses

Infectious Disease

Training Experience

2000Residency, Oregon Health Sciences University Hospital
2004Fellowship, University of Virginia Hospitals

Education/Academic qualification

MS, University of Virginia

… → 2004

MD, University of South Florida

… → 1997

Research interests

  • Immunization
  • Infectious Diseases
  • Infectious Diseases: Viral
  • Respiratory Diseases
  • Transplantation
  • Virology
  • Virus Diseases

Fingerprint Dive into the research topics where Michael G Ison is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 19 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Protocol No. P10934-CMVPS-CSP-01: Clinical Performance of the Aptima® CMV Quant Assay on the Panther® System

Ison, M. G.

Hologic, Inc.

5/2/19 → 5/2/22

Project: Research project

[U19] Integrated Genomics of Mucosal Infections: Viral Diversity and Pathogenicity in Mucosal Respiratory and Gastrointestinal Disease

Ison, M. G.

Baylor College of Medicine, National Institute of Allergy and Infectious Diseases

4/15/19 → 3/31/24

Project: Research project

    • Prot. CP40617 - A Phase III, Multicenter, Randomized, Double-Blind, Active-Controlled Study to Assess the Efficacy and Safety of Baloxavir Marboxil in Combination with a Neuraminidase Inhibitor versus a Neuraminidase Inhibitor Alone in Hospitalized Patien

    Ison, M. G.

    Syneos Health, Inc., Genentech, Inc.

    2/22/19 → 2/22/22

    Project: Research project

    Prot. Number IA-001: A Randomized, Double-Blind, Placebo-Controlled Dose Ranging Study Evaluating the Safety, Pharmacokinetics and Clinical Benefit of FLU-IGIV in Hospitalized Patients with Serious Influenza A Infection

    Ison, M. G.

    SGS North America Inc., Cangene Corporation

    12/15/17 → 12/15/20

    Project: Research project

    AIC316-03-II-01 A Randomized, Open Label, Multi-Center, Comparative Trial, to Assess the Efficacy and Safety of Pritelivir Versus Foscarnet for the Treatment of Acyclovir-Resistant Mucocutaneous HSV Infections in Immunocompromised Adults (PRIOH-1)

    Ison, M. G.

    Medpace, Inc., AiCuris Anti-infective Cures GmbH

    12/1/17 → 12/1/20

    Project: Research project

    Research Output

    Appropriateness of Beta-Lactam Allergy Record Updates After an Allergy Service Consult

    Shaw, B. G., Masic, I., Gorgi, N., Kalfayan, N., Gilbert, E. M., Barr, V. O., Ison, M. G. & McLaughlin, M. M., Jun 1 2020, In : Journal of Pharmacy Practice. 33, 3, p. 243-246 4 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial

    Ison, M. G., Portsmouth, S., Yoshida, Y., Shishido, T., Mitchener, M., Tsuchiya, K., Uehara, T. & Hayden, F. G., 2020, (Accepted/In press) In : The Lancet Infectious Diseases.

    Research output: Contribution to journal › Article

    • 3 Scopus citations

    Effect of Oral Oseltamivir on Virological Outcomes in Low-risk Adults With Influenza: A Randomized Clinical Trial

    Beigel, J. H., Manosuthi, W., Beeler, J., Bao, Y., Hoppers, M., Ruxrungtham, K., Beasley, R. L., Ison, M., Avihingsanon, A., Losso, M. H., Langlois, N., Hoopes, J., Lane, H. C., Holley, H. P., Myers, C. A., Hughes, M. D. & Davey, R. T., May 23 2020, In : Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 70, 11, p. 2317-2324 8 p.

    Research output: Contribution to journal › Article

    • 1 Scopus citations

    Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process

    Ison, M. G., Wolfe, C. & Boucher, H. W., 2020, (Accepted/In press) In : JAMA - Journal of the American Medical Association. 8863.

    Research output: Contribution to journal › Short survey

    Open Access
    5 Scopus citations

    KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors

    Mandelbrot, D. A., Reese, P. P., Garg, N., Thomas, C. P., Rodrigue, J. R., Schinstock, C., Doshi, M., Cooper, M., Friedewald, J., Naik, A. S., Kaul, D. R., Ison, M. G., Rocco, M. V., Verbesey, J., Hladunewich, M. A., Ibrahim, H. N. & Poggio, E. D., Mar 2020, In : American Journal of Kidney Diseases. 75, 3, p. 299-316 18 p.

    Research output: Contribution to journal › Article

    Open Access
    • 1 Scopus citations